文献速递区域麻醉与超声疼痛医学

地塞米松联合右美托咪定作为外周神经阻滞佐剂:系统评价与Meta分析

Effects of combined dexamethasone and dexmedetomidine as adjuncts to peripheral nerve blocks: a systematic review with meta-analysis and trial sequential analysis.
PubMed 文献 · Reg Anesth Pain Med · 2025-04-10

该系统评价纳入9项RCT(14个比较),评估地塞米松联合右美托咪定对外周神经阻滞镇痛时长的影响。联合方案较安慰剂和右美托咪定延长镇痛时长,但与地塞米松单用相似;证据确定性中等。若目标为延长镇痛,地塞米松单用似合理。

要点

  • 联合方案较安慰剂延长镇痛时长460分钟(95%CI 249-671)。
  • 联合方案较右美托咪定延长镇痛时长388分钟(95%CI 211-565)。
  • 联合方案与地塞米松单用在镇痛时长上可能相似。

核心结论

  • 地塞米松联合右美托咪定较安慰剂和右美托咪定可能延长镇痛时长,但与地塞米松单用可能相似。
  • 若目标为延长镇痛时长,地塞米松单用似乎是合理选择。

研究设计与样本

  • 系统评价与Meta分析,纳入9项RCT共14个合格比较,检索至2023年6月8日。
  • 联合方案 vs 安慰剂3项RCT(173例),vs 地塞米松7项(569例),vs 右美托咪定4项(281例)。

主要发现

  • 联合方案 vs 安慰剂镇痛时长平均差460分钟(95%CI 249-671)。
  • 联合方案 vs 右美托咪定镇痛时长平均差388分钟(95%CI 211-565)。
  • 联合方案 vs 地塞米松镇痛时长平均差50分钟(95%CI -140至239)。

关键数值与推荐

  • 主要结局为镇痛时长;采用Meta分析、试验序贯分析、ROB-2和GRADE评估。
  • 证据确定性为中等,因多数试验存在高偏倚风险。

临床怎么用

  • 若目标为延长外周神经阻滞镇痛时长,可考虑地塞米松单用而非联合右美托咪定。
  • 联合方案较右美托咪定单用可能延长镇痛时长,但需权衡证据确定性。

局限性

  • 多数纳入试验存在高偏倚风险,证据确定性为中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/IMPORTANCE: The effects of combining dexamethasone and dexmedetomidine on block duration are unclear. OBJECTIVE: To investigate the effects of combining dexamethasone and dexmedetomidine on block duration. EVIDENCE REVIEW: Systematic review of randomized controlled trials (RCTs) from Medline, Embase, CENTRAL, CINAHL, the Web of Science, and BIOSIS until June 8, 2023. RCTs with adults undergoing surgery with a peripheral nerve block randomized to combined dexamethasone and dexmedetomidine versus placebo or other adjuncts were eligible. Primary outcome was duration of analgesia. We performed meta-analysis, trial sequential analysis, risk of bias-2, and Grading Recommendations Assessment, Development, and Evaluation assessment. FINDINGS: We included 9 RCTs with 14 eligible comparisons. The combination of dexamethasone and dexmedetomidine was compared with placebo in three RCTs (173 participants), dexamethasone in seven (569 participants), and dexmedetomidine in four (281 participants). The duration of analgesia was likely increased with the combination versus placebo (mean difference 460 min, 95% CI 249 to 671) and versus dexmedetomidine (mean difference 388 min, 95% CI 211 to 565). The duration was likely similar with the combination versus dexamethasone (mean difference 50 min, 95% CI -140 to 239). The certainty of the evidence was moderate because most trials were at high risk of bias. CONCLUSIONS: Combined dexamethasone and dexmedetomidine likely increased the duration of analgesia when compared with placebo and dexmedetomidine. The combination likely provided a similar duration of analgesia as dexamethasone. Based on this systematic review, it seems reasonable to use dexamethasone as the sole adjunct if the goal is to increase the duration of analgesia.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Maagaard M, Andersen JH, Jaeger P, et al. Effects of combined dexamethasone and dexmedetomidine as adjuncts to peripheral nerve blocks: a systematic review with meta-analysis and trial sequential analysis. Reg Anesth Pain Med. 2025. PMID: 38253609. doi:10.1136/rapm-2023-105098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。